Disc Medicine, Inc. Investing Cash Flow
Disc Medicine, Inc. (IRON) reported Investing Cash Flow of $79.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-30
- Disc Medicine, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $21.63M, a 58.16% decline year-over-year.
- Disc Medicine, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $58.31M.
- Disc Medicine, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$222.89M.
- Disc Medicine, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $49.54M.
- Disc Medicine, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$394.30M.
- Disc Medicine, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$292.33M.
- Disc Medicine, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$89.00K.
- Disc Medicine, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$151.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $79.94M 10-Q · filed 2026-07-30 | -$142.96M derived: sum of 3 quarters · filed 2026-07-30 | -$93.42M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $58.31M 10-Q · filed 2026-05-05 | -$164.59M derived: sum of 2 quarters · filed 2026-05-05 | -$115.05M derived: sum of 3 quarters · filed 2026-05-05 | -$63.36M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | -$222.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$173.35M derived: sum of 2 quarters · filed 2026-02-26 | -$121.67M derived: sum of 3 quarters · filed 2026-07-30 | -$394.30M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $49.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $101.23M derived: sum of 2 quarters · filed 2026-07-30 | -$171.41M 10-Q · filed 2025-11-06 | -$172.83M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $51.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$220.94M 10-Q · filed 2026-07-30 | -$222.37M derived: sum of 3 quarters · filed 2026-07-30 | -$293.46M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | -$272.63M 10-Q · filed 2026-05-05 | -$274.06M derived: sum of 2 quarters · filed 2026-05-05 | -$345.15M derived: sum of 3 quarters · filed 2026-05-05 | -$564.90M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$72.52M derived: sum of 2 quarters · filed 2026-02-26 | -$292.26M derived: sum of 3 quarters · filed 2026-02-26 | -$292.33M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | -$71.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$290.84M derived: sum of 2 quarters · filed 2025-11-06 | -$290.91M 10-Q · filed 2025-11-06 | -$290.91M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$219.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$219.82M 10-Q · filed 2025-08-07 | -$219.82M derived: sum of 3 quarters · filed 2026-02-26 | -$219.86M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$67.00K 10-Q · filed 2025-05-07 | -$70.00K derived: sum of 2 quarters · filed 2026-02-26 | -$115.00K derived: sum of 3 quarters · filed 2026-02-26 | -$127.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$48.00K derived: sum of 2 quarters · filed 2026-02-26 | -$60.00K derived: sum of 3 quarters · filed 2026-02-26 | -$89.00K 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$57.00K derived: sum of 2 quarters · filed 2024-11-12 | -$86.00K 10-Q · filed 2024-11-12 | -$98.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$41.00K 10-Q · filed 2024-08-08 | -$53.00K derived: sum of 3 quarters · filed 2024-08-08 | -$72.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$29.00K 10-Q · filed 2024-05-09 | -$41.00K derived: sum of 2 quarters · filed 2024-05-09 | -$60.00K derived: sum of 3 quarters · filed 2024-05-09 | -$80.00K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$31.00K derived: sum of 2 quarters · filed 2024-03-21 | -$51.00K derived: sum of 3 quarters · filed 2024-03-21 | -$151.00K 10-K · filed 2024-03-21 | ||
| 2022-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$39.00K derived: sum of 2 quarters · filed 2023-11-09 | -$139.00K 10-Q · filed 2023-11-09 | $0.00 10-Q · filed 2022-11-10 | -$146.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$120.00K 10-Q · filed 2023-08-11 | -$127.00K derived: sum of 3 quarters · filed 2023-08-11 | |||
| 2022-03-31 | -$100.00K 10-Q · filed 2023-05-15 | -$107.00K derived: sum of 2 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$68.00K 10-K · filed 2023-03-31 | $344.00K 10-K · filed 2022-03-10 | |||
| 2021-09-30 | -$61.00K 10-Q · filed 2022-11-10 | |||||
| 2020-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-29 | -$120.75M 10-K · filed 2021-03-29 | -$22.00K 10-K · filed 2022-03-10 | |||
| 2020-09-30 | -$120.75M 10-Q · filed 2020-11-12 | -$22.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |